Safety and Tolerability of Tolvaptan in an Autosomal Dominant Polycystic Kidney Disease Spanish Cohort: A Real-World Experience

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited disorder of the kidneys. A vasopressin V2-receptor antagonist (tolvaptan) was recently approved for the treatment of ADPKD. This study aims to analyze the safety and tolerability of tolvaptan for the manage...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cureus
Hlavní autoři: Guerra-Torres, Xavier E, Peña Esparragoza, J, Perez Fernandez, M, Fernandez Rodríguez, M, Mancha Ramos, J, Martinez Miguel, P, Rodriguez Puyol, D, Bouarich, H
Médium: Artigo
Jazyk:Inglês
Vydáno: Cureus 2020
Témata:
Internal Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532866/
https://ncbi.nlm.nih.gov/pubmed/33033683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10207
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky